Skip to main content
Sorafenib Plus TACE Prolongs Survival in Recurrent HCC
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Sorafenib Plus TACE Prolongs Survival in Recurrent HCC
User login
Username
Password
Reset your password
Concept
Lead
score
Hepatocellular Carcinoma
1
1
Aminotransferase
0
0.52
Hospital
0
0.52
Platelet-Derived Growth Factor
0
0.36
Cancer
0
0.26
Hepatitis
0
0.26
Hepatitis A
0
0.26
Platelet Count
0
0.26
Prognosis
0
0.26
Receptors
0
0.26
Vascular Endothelial Growth Factor
0
0.26
Hepatitis B Virus
0
0.23
Hepatitis C Virus
0
0.14
Specialty
Lead
score
Hematology-Oncology
1
1
Gastroenterology
0
0.9
Edit Tags